During the past decade, Practice Dr.med. Denger and Dr.med. Pfitzner conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Practice Dr.med. Denger and Dr.med. Pfitzner" are "Type 2 Diabetes Mellitus" (2 trials), "Crohn's Disease" (1 trials) and "Type 1 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Practice Dr.med. Denger and Dr.med. Pfitzner" in a lesser frequency.

Most popular intervention types in "Practice Dr.med. Denger and Dr.med. Pfitzner" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Insulin Degludec" (2 trials), "LY3209590" (2 trials), "Dulaglutide" (1 trials), "Mirikizumab" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Practice Dr.med. Denger and Dr.med. Pfitzner" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Practice Dr.med. Denger and Dr.med. Pfitzner". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Practice Dr.med. Denger and Dr.med. Pfitzner, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Practice Dr.med. Denger and Dr.med. Pfitzner, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".